Kaplan, M. Et Al. 2021. Elabela as a novel marker: Well-correlated with WIfI amputation risk score in lower extremity arterial disease patients. ANATOLIAN JOURNAL OF CARDIOLOGY , vol.25, no.5 , 330-337.

Kaplan, M., Yavuz, F., Kaplan, G. I., BURSA, N., VURUŞKAN, E., & Sucu, M., (2021). Elabela as a novel marker: Well-correlated with WIfI amputation risk score in lower extremity arterial disease patients. ANATOLIAN JOURNAL OF CARDIOLOGY , vol.25, no.5, 330-337.

Kaplan, Mehmet Et Al. "Elabela as a novel marker: Well-correlated with WIfI amputation risk score in lower extremity arterial disease patients," ANATOLIAN JOURNAL OF CARDIOLOGY , vol.25, no.5, 330-337, 2021

Kaplan, Mehmet Et Al. "Elabela as a novel marker: Well-correlated with WIfI amputation risk score in lower extremity arterial disease patients." ANATOLIAN JOURNAL OF CARDIOLOGY , vol.25, no.5, pp.330-337, 2021

Kaplan, M. Et Al. (2021) . "Elabela as a novel marker: Well-correlated with WIfI amputation risk score in lower extremity arterial disease patients." ANATOLIAN JOURNAL OF CARDIOLOGY , vol.25, no.5, pp.330-337.

@article{article, author={Mehmet Kaplan Et Al. }, title={Elabela as a novel marker: Well-correlated with WIfI amputation risk score in lower extremity arterial disease patients}, journal={ANATOLIAN JOURNAL OF CARDIOLOGY}, year=2021, pages={330-337} }